This website provides information about laboratory diagnostic services. The analyses presented are not therapeutic and do not replace medical diagnosis and treatment. Medical decisions are made exclusively by your treating physician.

Welcome to your competent partner for tumor diagnostics physicians! As a specialized laboratory for physicians, we support you with precise cancer diagnostics physicians expertise for optimal patient care with physicians cancer tests.

Our diagnostics laboratory offers you fast and reliable results for your cancer diagnostics practice. As an experienced oncology laboratory partner, we understand the special requirements of tumor medicine. The tumor diagnostics practice is seamlessly integrated into your existing workflows.

With our diagnostics partner oncology service, you not only receive medical cancer test results, but also expert advice and interpretation. Our therapists tumor test support will help you with complex diagnostic questions for the best possible patient care.

Molecular biological precision diagnostics for your oncology patients

Dear Colleagues,

As a partner in oncology, we offer you innovative molecular biological diagnostic solutions that go beyond standard therapy and open up new perspectives for your patients. Our Liquid Biopsy technology enables the identification of individual therapy options through precise analysis of resistance mechanisms and metabolic pathways of tumor cells.

labor für ärzte

Personalized cancer diagnostics in practice

Guide

Our differentiation from standard diagnostics

Conventional guideline-based oncology offers proven therapy protocols, but reaches its limits with different and possibly therapy-resistant tumors or rare molecular subtypes. This is where our personalized diagnostics come in:

  • Individualized analysis instead of statistical categorization
  • Identification of active metabolic and signaling pathways by mRNA expression analysis
  • Comprehensive proof of resistance mechanisms and alternative signaling pathways
  • Comparison with databases of approved active ingredients for immediate clinical applicability
präzisionsdiagnostik krebs

Early recognition and action

Basis of our methodology

Our diagnostics are based on the analysis of circulating tumor cells (CTCs) and cell-free tumor DNA/RNA using Liquid Biopsy. This approach offers decisive advantages over conventional biopsies:

  1. Minimally invasive sample collection without stressing the patient
  2. Detection of tumor heterogeneity through representation of different tumor cell populations
  3. Longitudinal monitoring of tumor evolution and treatment resistance
  4. Early detection of molecular changes before clinical manifestation

Using highly sensitive enrichment methods, we can achieve reliable results even at low CTC concentrations.

Laboratory for doctors – your competent diagnostic partner

Our laboratory for physicians offers you the complete spectrum of modern tumor diagnostics. The diagnostiklabor ärzte team works closely with you for optimal patient results. As a laboratory for physicians, we understand the specific requirements of your daily practice.

Cancer diagnostics practice – seamless integration into your workflow

krebsdiagnostik praxis integration is uncomplicated and efficient. Our tumordiagnostik praxis solutions adapt flexibly to your workflows. With krebsdiagnostik praxis services, you optimize your patient care and save valuable time.

Laboratory partner in oncology – expertise for complex cases

As laborpartner on kologie, we have many years of experience in tumor diagnostics. Our diagnostikpartner onkologie team is on hand to advise you in difficult cases. The laborpartner onkologie service also includes telephone consultations and therapy recommendations.

Doctors cancer test – Fast and precise results

Our ärzte krebstest procedures provide you with reliable results in the shortest possible time. The therapist tumor test support includes all modern diagnostic procedures. We use our ärzte krebstest expertise to help you plan the best treatment for your patients.

Indications for our analyses

Our diagnostics are particularly valuable for patients in the following situations:

Clinical relevance of our analyses

The molecular characterization of the tumor cells makes this possible:

Practical course of the cooperation

The process for you as the treating physician is straightforward:

1

Contact us

By telephone or e-mail for an initial case discussion

2

Material dispatch

We will send you specialized blood collection kits free of charge

General information

Test order: Please fill out the test order and make sure that the necessary signatures of the patient and attending physician are on page 4. Enter all the information you have so that the analysis can be carried out without delay. Place the examination order together with the samples to be analyzed in the appropriate box and, if available, also enclose other documents such as current doctor’s letters, pathology reports or treatment plans.

3

Sampling

Standard blood collection (for chemotherapy, radiotherapy, operations, observe an interval of at least 12 days)

Guide for blood samples

Collection of the sample: Please fill the enclosed serumtube 1 first (BD Vacutainer CAT with red cap). Then fill the tubes 2 to 5 (BD Vacutainer K2E with purple cap) as much as possible to obtain a total of approx. 40 ml of blood. The blood must not be infectious.

Collection: Please contact us at least one day before the blood sample is taken so that we can organize a timely collection by courier service. If logistically possible, the samples must reach us within 24 hours.

It is therefore not possible to take blood samples on Fridays or before public holidays.

Storage: The sample can be stored in the refrigerator (4 °C – 8 °C) until the courier picks it up. Please note, however, that the blood must not freeze under any circumstances, as the sample cannot be used in this case.

Guide for tissue samples

Fresh tissue: When sending fresh tissue, please contact us at least three days before the biopsy/surgery. Fresh tissue must be transported on dry ice, which we send to the clinic in advance. Please transfer the tissue samples to the enclosed screw-top containers and place them back on the dry ice immediately so that the cold chain is not interrupted.

Kerosene block: Express delivery is not necessary for tissue embedded in kerosene (FFPE).

4

Collection

Our courier service collects the sample directly from your practice

Collection:
Please note that the courier service requires a time window of at least 2 hours.
Therefore, please contact us at least one day before the blood collection so that we can organize a timely collection by courier service. If logistically possible, the samples must reach us within 24 hours. It is therefore not possible to take blood samples on Fridays or before public holidays.

5

Analysis

Comprehensive molecular biological characterization in the laboratory

6

Transmission of findings and case discussion

You will receive a detailed report with clinically relevant treatment options.

If required, our scientific experts will explain the results.

7

Cost absorption and billing

As an innovative diagnostic procedure, our analysis is currently not a standard service provided by statutory health insurance. However, we offer various options:

  • Private patients: Billing according to GOÄ possible
  • Self-payers: transparent price structure with detailed breakdown

We will be happy to provide you with individual advice on billing issues.

We offer specialized analyses for different tumor entities

Tumor-specific expertise

Diagnostic options:

Gaining insights

The analysis: cancer cells along the timeline

Our laboratory focuses on isolating circulating tumor cells from patients’ blood and deciphering their secrets.

Cancer prevention /
Cancer monitoring

Stage 0

iPREVENT

Preventive early tumor detection and aftercare following previous cancer

Do I have cancer?” Early monitoring of a previous cancer: “Will my cancer come back?”

Local
Tumor

Stage 1,2

iSELECT

Diagnostics for complementary substances

Which complementary substances fight my cancer most effectively?”

Natural substances with few side effects and off-label drugs in stage 1 – 2.

Tumor in
lymph nodes

iCOMPLETE

Comprehensive diagnostics for tumors with lymph node involvement

Which conventional and complementary therapy is best for me?”

Stage 3

Tumor with
metastases

iCOMPLETE

Comprehensive diagnostics for metastatic tumors

“Which conventional medical and complementary therapy has maximum effectiveness with minimum side effects?”

Stage 4

We are open to scientific cooperation with clinical institutions:

Scientific cooperation

Personalized cancer diagnostics depending on the stage

Our tests: Individual offers for cancer diagnostics in your practice

Our innovative approach to personalized cancer diagnostics supports the treatment of patients at their respective stage – from early detection to advanced treatment. Through molecular biological analysis, we identify the individual characteristics of each tumor and its weak points. Discover our specific offers for your patients:

tumor diagnostics cancer

iPREVENT

The blood test for early detection or monitoring of cancer

cancer diagnostics

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

Runs a full panel of 34 gene expressions+ gene expressions and analyzes which natural substances or off-label drugs will dampen the over-expressed genes.

Liquid Biopsy for cancer

iCOMPLETE

The blood test for comprehensive analysis of your tumor activity.

Runs a full panel of 85+ gene expressions and analyzes which approved drugs, including chemotherapeutics, targeted drugs and immunotherapies, as well as natural compounds or off-label drugs, will dampen the overexpressed genes.

Ein informativer Tag mit einzigartigen Rednern

Treffen Sie uns auf dem iQMedix Therapeutenkongress

Am 21. März 2026

Melden Sie sich an.

Seien Sie unser Gast, wir freuen uns auf Ihre Sie!
Die Teilnahme, Kaffeepausen & Mittagessen sind kostenlos.

tumor diagnostics physicians

Contact us at any time

CONTACT FORM DOCTOR

We take the time for you

Sie fragen, wir antworten

Haben Sie Fragen? Hier finden Sie ANtworten!

Was ist die Testung genetischer Expressionswerte von Krebszellen?

Durch molekularbiologische Analyse identifizieren wir das individuelle Aktionsprofil eines Tumors und finden die therapeutischen Angriffspunkte.

Die Messung der RNA-Genexpressionswerte ist dem Tumorgeschehen näher als eine reine Mutationsanalyse. Mit dieser Messung kann man für wichtige Signalwege des Tumors das konkrete und aktuelle Aktionsprofil und deren Eigenschaften ermitteln.

Per Flüssigbiopsie ist eine Gewinnung frischer lebender Tumorzellen einfach und schmerzfrei möglich.  

Es werden auch Tumorzellen aus Körperregionen gewonnen, die wie in Lunge, Bauchspeicheldrüsen oder Gehirn für herkömmliche Gewebebiopsien oft nur schwierig zu erreichen sind.

Man kann weiterhin auch Tumorzellen aus Urin, Aszites oder Liquor erhalten.

Wenn Gewebebiopsate vorliegen, kann man auch diese nutzen. Somit sind vielfältige Möglichkeiten gegeben, um Tumorzellen zu gewinnen.

Die iSelect und iComplete Tests liefern entscheidende Erkenntnisse bezüglich:

• der Aggressivität des Tumors

• der Manipulation des Immunsystems durch den Tumor

• der Resistenzen gegenüber Medikamenten

• der Aktivität relevanter Signale

• der Wirksamkeit bestimmter Substanzen

Die Messergebnisse werden therapeutischen Substanzen zugeordnet, basierend auf anerkannten Studien, sodass der behandelnde Arzt Optionen für eine gezielte Therapie erhält.

Üblicherweise werden die Tumorzellen aus einer Blutprobe extrahiert, gefolgt von der Analyse der RNA, um die Aktivität von Genen zu bestimmen. Die Tumorzellen können aber auch aus einer Biopsie, Liquor oder Aszites entnommen werden.

Die mit dem iSelect oder iComplete Test gewonnen Therapieoptionen zeigen personalisierte und für den individuellen Tumor zielgerichtete Therapieoptionen auf, die der Therapeut umsetzen kann. Weiterhin werden auch individuell für den vorliegenden Tumor ungeeignete Substanzen die z.B. in der Chemotherapie eingesetzt werden, aufgezeigt. Damit kann man z.B. stark toxische Therapeutika, die der Tumor einfach durchschleust, identifizieren und für die Therapie ausschließen.

Bitte sprechen Sie uns über die kostenlose Beratung an, damit wir den richtigen Test herausfinden und Ihnen die damit verbundenen Kosten mitteilen können.

Die Laborarbeit dauert ca. 10 Arbeitstage. Danach wird ein Bericht geschrieben, der je nach Komplexität des Falles ca. 1 – 3 Arbeitstage dauern kann. Der Bericht muss wegen gesetzlicher Vorgaben im Falle von Krebs an den behandelnden Arzt gehen. Er kann dann den Bericht an den Patienten weiterleiten.

Die Zuverlässigkeit hängt von verschiedenen Faktoren ab, einschließlich der Testmethode und der Qualität der genommenen Probe. In vielen Fällen sind Liquid Biopsy-Tests jedoch eine zuverlässige Ergänzung zu anderen Diagnosemethoden.

1

Kontaktieren Sie uns und bestellen Sie das Blutabnahmeset für Ihren Arzt

Rufen Sie bei uns an oder schicken Sie uns eine Nachricht. Wir beraten Sie zu unseren Tests. Das entsprechende Blutentnahmeset lassen wir Ihrem Arzt kostenlos zukommen.

2

Vereinbaren Sie einen Termin zur Blutabnahme bei Ihrem Arzt

Die Blutabnahme erfolgt bei dem Arzt Ihres Vertrauens oder einem Arzt unseres Netzwerkes. Wichtig für Chemotherapie-Patienten: Planen Sie diesen Termin frühestens 10-14 Tage nach Ihrer letzten Chemotherapie.

3

Ihr Arzt oder Sie:
Informieren Sie uns über Ihren Blutabnahmetermin

Teilen Sie uns spätestens einen Tag vor der geplanten Blutabnahme per E-Mail oder telefonisch mit, wann und wo die Probe abgeholt werden soll. Wir benötigen Ort, Datum und ein Zeitfenster von 2 Stunden für unseren Kurierdienst.

Nur so können wir die Abholung der Probe in Ihrer Praxis organisieren.

4

Nehmen Sie das Blutabnahmeset zum Arzttermin mit

Bringen Sie das von uns erhaltene Blutabnahmeset zu Ihrem Arzttermin mit. Nach der Blutabnahme wird die Probe durch unseren Kurierdienst abgeholt und zu unserem Labor transportiert.

5

LASSEN SIE DURCH IHREN ARZT DIE UNTERLAGEN AUSFÜLLEN, UNTERSCHREIBEN SIE DEN AUFTRAG und senden Sie sie zurück

  • Prüfen Sie die Vollständigkeit der beiliegenden Unterlagen
  • Lassen Sie den Arzt den Auftrag zur molekularen Diagnostik mit Ihrer Einwilligung und Unterschrift ausfüllen
  • Ergänzen Sie den beiliegenden Medikamentenplan
  • Legen Sie Kopien Ihrer Klinik-Berichte/Anamnesen bei
  • Senden Sie alle Formulare unterschrieben im Original an uns zurück

6

Besprechen Sie die Ergebnisse mit Ihrem Arzt

Die Berichterstellung erfolgt nach Zahlungseingang des Patienten je nach Fall innerhalb von ca. 10-15 Werktagen.

Vereinbaren Sie einen Beratungstermin mit Ihrem Arzt zur Besprechung der Testergebnisse. Wir senden  den Testbericht direkt an Ihren Arzt.

Kontaktieren Sie uns zu jeder Zeit

Wir nehmen uns die zeit für Sie

Contact us at any time

CONTACT FORM PATIENT

We take the time for you

We wish you a pleasant journey

Contact us at any time

CONTACT FORM DOCTOR

We take the time for you

tumor diagnostics cancer

iPREVENT

The blood test for early detection or monitoring of cancer

Tumors release cancer cells into the blood (circulating tumor cells – CTC) at a very early stage. If these cells settle elsewhere in the body, they develop into metastases. iPREVENT often detects circulating tumor cells in the blood at a very early stage, when imaging methods (ultrasound, CT, MRI) do not yet show anything.

If a large number of such cells are found, the iSelect or iComplete test can be connected.
This means that tumors can usually be detected at an early stage and treated appropriately. Early treatment usually significantly increases success and the chances of survival. The gentler treatment options in the early stages also mean that significantly fewer side effects can be expected.

THE iPREVENT TEST OFFERS DECISIVE ADVANTAGES:

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

cancer diagnostics

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

The iSELECT test evaluates tumor cells for the expression of 35 genes. Gene expression profiles describe the extent to which a gene is active and, consequently, the signaling and metabolic pathways within the tumor cell that depend on it. The test focuses on genes that are particularly important for tumor growth and that characterize the cancer. The advantage of the test is that the analysis of these characteristics generates a personalized activity profile of the tumor.

By comparing the data with scientific studies, potential complementary substances (plant-based substances and off-label medications) are identified and compiled for medical evaluation. The results are tailored to the specific stage of the disease and are intended to serve as the basis for a complementary treatment approach that is as gentle as possible. They are presented in an easy-to-understand, detailed report.

As the disease progresses, the test is used during and after cancer treatment to identify changes in signaling and metabolic pathways that may indicate a recurrence. Treatment can then be adjusted accordingly.

THE iSELECT TEST PROVIDES INFORMATION ON:

You will receive a detailed report containing the analysis results and references that your medical team can take into account when planning your treatment.

Important: The interpretation of the results and all treatment decisions are made exclusively by your treating physicians.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

PATIENT CONTACT FORM

We take the time for you

Liquid Biopsy for cancer

iCOMPLETE

LABORATORY DIAGNOSTIC TEST FOR THE MOLECULAR ANALYSIS OF GENE EXPRESSION PATTERNS IN TUMOR DISEASES

The iCOMPLETE test analyzes a panel of 85+ gene expressions. The test focuses on genes associated with tumor growth and tumor characteristics.

The iCOMPLETE test identifies molecular activity patterns regardless of tumor type and provides information on potential treatment approaches to serve as a basis for clinical treatment decisions. The analysis can help treating physicians select personalized treatment options based on each patient’s individual profile.

The iCOMPLETE test analyzes gene expression profiles from the patient’s blood. Gene expression provides information about the extent to which a gene is active and which signaling and metabolic pathways in the tumor cell may be associated with it.

Based on scientific studies, the iCOMPLETE test identifies approved medications—including chemotherapy drugs, targeted therapies, and immunotherapies—as well as natural substances or off-label medications associated with the signaling or metabolic pathways under investigation. The results are presented in a structured laboratory report.

Throughout the course of the disease, testing during and after cancer treatment can provide information about changes in signaling and metabolic pathways. This molecular information can help the treating physician adjust the treatment plan.

IMPORTANT INFORMATION ON TEST INTERPRETATION:

This test provides molecular biological information about your tumor. It does not constitute a treatment recommendation. The substances mentioned in the report are based on scientific publications and should be understood as potential points of consideration for medical evaluation.

The selection, prescription, and dosage of all medications and substances—including herbal active ingredients—are determined exclusively by your treating physician, taking into account your overall medical condition.

The effectiveness of the substances mentioned cannot be guaranteed in individual cases. Off-label medications and herbal supplements can also cause side effects and interactions.

Note on Off-Label Medications: The use of medications outside their approved indications (off-label use) is at your doctor’s discretion and at your own risk. No standard clinical trials have been conducted for these uses.

THE iCOMPLETE TEST PROVIDES INFORMATION ON:

The laboratory report presents research-based information on conventional and complementary treatment approaches that are related to the identified molecular patterns based on gene expression analysis. This information serves as a basis for treating physicians to make individualized treatment decisions.

Important: The interpretation of the results and all treatment decisions are made exclusively by your treating physicians.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

PATIENT CONTACT FORM

We take the time for you

tumor diagnostics cancer

iPREVENT

The blood test for early detection or monitoring of cancer

Tumors release cancer cells into the blood (circulating tumor cells – CTC) at a very early stage. If these cells settle elsewhere in the body, they develop into metastases. iPREVENT often detects circulating tumor cells in the blood at a very early stage, when imaging methods (ultrasound, CT, MRI) do not yet show anything.

If a large number of such cells are found, the iSelect or iComplete test can be connected.
This means that tumors can usually be detected at an early stage and treated appropriately. Early treatment usually significantly increases success and the chances of survival. The gentler treatment options in the early stages also mean that significantly fewer side effects can be expected.

THE iPREVENT TEST OFFERS DECISIVE ADVANTAGES:

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

cancer diagnostics

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

The iSELECT test evaluates tumor cells for the expression of 35 genes. Gene expression profiles describe the extent to which a gene is active and, consequently, the signaling and metabolic pathways within the tumor cell that depend on it. The test focuses on genes that are particularly important for tumor growth and that characterize the cancer. The advantage of the test is that the analysis of these characteristics generates a personalized activity profile of the tumor.

By comparing the data with scientific studies, potential complementary substances (plant-based substances and off-label medications) are identified and compiled for medical evaluation. The results are tailored to the specific stage of the disease and are intended to serve as the basis for a complementary treatment approach that is as gentle as possible. They are presented in an easy-to-understand, detailed report.

As the disease progresses, the test is used during and after cancer treatment to identify changes in signaling and metabolic pathways that may indicate a recurrence. Treatment can then be adjusted accordingly.

THE iSELECT TEST PROVIDES INFORMATION ON:

You will receive a detailed report containing the analysis results and references that your medical team can take into account when planning your treatment.

Important: The interpretation of the results and all treatment decisions are made exclusively by your treating physicians.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

PATIENT CONTACT FORM

We take the time for you

Liquid Biopsy for cancer

iCOMPLETE

LABORATORY DIAGNOSTIC TEST FOR THE MOLECULAR ANALYSIS OF GENE EXPRESSION PATTERNS IN TUMOR DISEASES

The iCOMPLETE test analyzes a panel of 85+ gene expressions. The test focuses on genes associated with tumor growth and tumor characteristics.

The iCOMPLETE test identifies molecular activity patterns regardless of tumor type and provides information on potential treatment approaches to serve as a basis for clinical treatment decisions. The analysis can help treating physicians select personalized treatment options based on each patient’s individual profile.

The iCOMPLETE test analyzes gene expression profiles from the patient’s blood. Gene expression provides information about the extent to which a gene is active and which signaling and metabolic pathways in the tumor cell may be associated with it.

Based on scientific studies, the iCOMPLETE test identifies approved medications—including chemotherapy drugs, targeted therapies, and immunotherapies—as well as natural substances or off-label medications associated with the signaling or metabolic pathways under investigation. The results are presented in a structured laboratory report.

Throughout the course of the disease, testing during and after cancer treatment can provide information about changes in signaling and metabolic pathways. This molecular information can help the treating physician adjust the treatment plan.

IMPORTANT INFORMATION ON TEST INTERPRETATION:

This test provides molecular biological information about your tumor. It does not constitute a treatment recommendation. The substances mentioned in the report are based on scientific publications and should be understood as potential points of consideration for medical evaluation.

The selection, prescription, and dosage of all medications and substances—including herbal active ingredients—are determined exclusively by your treating physician, taking into account your overall medical condition.

The effectiveness of the substances mentioned cannot be guaranteed in individual cases. Off-label medications and herbal supplements can also cause side effects and interactions.

Note on Off-Label Medications: The use of medications outside their approved indications (off-label use) is at your doctor’s discretion and at your own risk. No standard clinical trials have been conducted for these uses.

THE iCOMPLETE TEST PROVIDES INFORMATION ON:

The laboratory report presents research-based information on conventional and complementary treatment approaches that are related to the identified molecular patterns based on gene expression analysis. This information serves as a basis for treating physicians to make individualized treatment decisions.

Important: The interpretation of the results and all treatment decisions are made exclusively by your treating physicians.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

PATIENT CONTACT FORM

We take the time for you

Contact us at any time

CONTACT FORM PATIENT

We take the time for you

We wish you a pleasant journey